Ahd: Zydus drug gets nod for third phase trials

Zydus Cadila on Friday announced that the company has received an approval from the Drugs Controller General of India (DCGI) to begin the phase-III clinical trials with its biological therapy — Pegylated Interferon alpha-2b (PegiHep) — in Covid-19 patients. PegiHep is an approved drug and is being re-purposed for the treatment of Covid-19.

from Ahmedabad News, Latest Ahmedabad News Headlines & Live Updates - Times of India https://ift.tt/2Jt08ch